MIAMI--(SafeStitch Medical®, Inc. (OTCBB: SFES), will attend the American College of Surgeons Annual Clinical Congress (ACS) in Chicago, IL, October 1-3, 2012 to present the AMID™ Hernia Fixation Device (AMID HFD™). The ACS is a scientific and educational organization of surgeons whose purpose is to raise the standards of surgical practice and improve the care of the surgical patient. Approximately 9,000 domestic and international surgeons are expected to attend.)--
“Being one of the largest surgical meetings in the US, it is with much enthusiasm that we again exhibit at the ACS to enlighten physicians about the unique features of the AMID HFD and how it can help patients with a fast and safe procedure”
SafeStitch Medical representatives will meet with current customers as well as interact with new prospects. The show will provide an opportunity to demonstrate the AMID HFD, offer training on the Simplified Stapled Lichtenstein Procedure (SSLP™), and present an instructional video at the exhibit booth.
“Being one of the largest surgical meetings in the US, it is with much enthusiasm that we again exhibit at the ACS to enlighten physicians about the unique features of the AMID HFD and how it can help patients with a fast and safe procedure,” said Jeffrey Spragens, President and CEO of SafeStitch Medical.
The AMID Hernia Fixation Device is used for both inguinal and ventral hernia surgeries. For inguinal hernia repair using the Lichtenstein method, the innovative design of the AMID HFD fixates mesh by delivering staples in a parallel plane to the femoral vessels, which may help avoid vascular injury. The AMID HFD allows for mesh manipulation, mesh fixation and skin closure.
The American College of Surgeons Annual Clinical Congress is being held at the McCormick Place West in Chicago, IL, October 1-3, 2012. Please visit booth #1031 in Exhibit Hall F2 to learn more about the AMID Hernia Fixation Device.
The AMID Hernia Fixation Device is sold nationwide.
About SafeStitch Medical, Inc.
Miami, Florida-based SafeStitch Medical, Inc. is a publicly traded medical device company founded by Charles J. Filipi M.D. and Jeffrey G. Spragens, in 2005, to develop a prototype for a minimally invasive obesity procedure. In the summer of 2006, Phillip Frost M.D., Chairman and CEO of OPKO Health, Inc. and Jane Hsiao Ph.D., Vice-Chairman and Chief Technical Officer of OPKO Health, Inc. became partners in SafeStitch Medical, Inc. and expanded SafeStitch’s mission to develop and market the best in class disposable medical devices to advance minimally invasive surgery for hernia repair, treatment of obesity and other gastroesophageal disorders. Information about the Company may be found on its website at: www.safestitch.com.
This press release contains "forward-looking statements," as that term is defined under the Private Securities Litigation Reform Act of 1995 (PSLRA), which statements may be identified by words such as "expects," "plans," "projects," "will," "may," "anticipate," "believes," "should," "intends," "estimates," and other words of similar meaning, including statements regarding our product development and commercialization efforts, and our ability to significantly improve clinical outcomes in patients, as well as other non-historical statements about our expectations, beliefs or intentions regarding our business, technologies and products, financial condition, strategies or prospects. Many factors, including those described herein and in our filings with the Securities and Exchange Commission, could cause our actual activities or results to differ materially from the activities and results anticipated in forward-looking statements. These factors include: whether the AMID HFD may help avoid vascular injury and how the AMID HFD can help patients with a fast and safe procedure. The forward-looking statements contained in this press release speak only as of the date the statements were made, and we do not undertake any obligation to update forward-looking statements, except as required under applicable law. We intend that all forward-looking statements be subject to the safe-harbor provisions of the PSLRA.